Cholangitis
38
2
3
16
Key Insights
Highlights
Success Rate
73% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
15.8%
6 terminated out of 38 trials
72.7%
-13.8% vs benchmark
11%
4 trials in Phase 3/4
13%
2 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (38)
Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis
aScope Single Use ERCP Study- ASSURE Study
Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Cholangitis Post Kasai in Biliary Atresia)
Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.
Optimal Placement Duration of Pancreatic Duct Stent
Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy
Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
Single Use ERCP Performance -SURE Study
preGallstep - A Clinical Pilot Trial
Efficacy of Single Use Disposable Elevator Cap (DEC) Duodenoscopy
Antibiotics to Decrease Post ERCP Cholangitis
Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI)
Definition for Biliary Atresia Associated Cholangitis After Surgery
Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
Microbial Analysis in Patients With Cholangitis
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital